Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● The company's attractive earnings multiples are brought to light by a P/E ratio at 9.89 for the current year.

● The company appears to be poorly valued given its net asset value.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● This company will be of major interest to investors in search of a high dividend stock.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The opinion of analysts covering the stock has improved over the past four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● With an enterprise value anticipated at 3.69 times the sales for the current fiscal year, the company turns out to be overvalued.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● Over the past four months, analysts' average price target has been revised downwards significantly.